OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
JAK/STAT blockade reverses the malignant phenotype of Hodgkin and Reed-Sternberg cells
Sara Monzón, José Luis Solórzano, Eva Díaz, et al.
Blood Advances (2022) Vol. 7, Iss. 15, pp. 4135-4147
Open Access | Times Cited: 6
Sara Monzón, José Luis Solórzano, Eva Díaz, et al.
Blood Advances (2022) Vol. 7, Iss. 15, pp. 4135-4147
Open Access | Times Cited: 6
Showing 6 citing articles:
Remission of relapsed/refractory classical Hodgkin lymphoma induced by brentuximab vedotin and pembrolizumab combination after allogeneic hematopoietic stem cell transplantation: a case report
Federica Giannotti, Carmen De Ramón Ortiz, Federico Simonetta, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Federica Giannotti, Carmen De Ramón Ortiz, Federico Simonetta, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Advances in Hodgkin Lymphoma Treatment: From Molecular Biology to Clinical Practice
C. Savelli, Matteo Bisio, Luca Legato, et al.
Cancers (2024) Vol. 16, Iss. 10, pp. 1830-1830
Open Access | Times Cited: 1
C. Savelli, Matteo Bisio, Luca Legato, et al.
Cancers (2024) Vol. 16, Iss. 10, pp. 1830-1830
Open Access | Times Cited: 1
Multiplex spatial analysis reveals increased CD137 expression and m-MDSC neighboring tumor cells in refractory classical Hodgkin Lymphoma
José Luis Solórzano, Victoria Menéndez, Edwin R. Parra, et al.
OncoImmunology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
José Luis Solórzano, Victoria Menéndez, Edwin R. Parra, et al.
OncoImmunology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Targeting the JAK-STAT pathway in colorectal cancer: mechanisms, clinical implications, and therapeutic potential
Penghui Li, Di Huang
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access
Penghui Li, Di Huang
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access
Protein kinase CK2α is overexpressed in classical hodgkin lymphoma, regulates key signaling pathways, PD-L1 and may represent a new target for therapy
Edoardo Ruggeri, Federica Frezzato, Nayla Mouawad, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Edoardo Ruggeri, Federica Frezzato, Nayla Mouawad, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
BET inhibitors induce NF-κB and E2F downregulation in Hodgkin and Reed–Sternberg cells
Sara Monzón, Eva Díaz, Claudia Geraldine Rita, et al.
Experimental Cell Research (2023) Vol. 430, Iss. 2, pp. 113718-113718
Closed Access
Sara Monzón, Eva Díaz, Claudia Geraldine Rita, et al.
Experimental Cell Research (2023) Vol. 430, Iss. 2, pp. 113718-113718
Closed Access
